Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | CTSG | P08311 | 1/20 | 0.36 |
| ▸ | CTRC | Q99895 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7212105 | 0.84 | L3MBTL1 (0.42) | L3MBTL1ACHETSHR | |
| SCHEMBL15460601 | 0.80 | GAA (0.39) | L3MBTL1ACHETSHR | |
| SCHEMBL7687781 | 0.79 | TSHR (0.30) | TSHR | |
| SCHEMBL14423078 | 0.79 | — | — | |
| SCHEMBL8892280 | 0.79 | MGLL (0.41) | ACHE | |
| SCHEMBL1106711 | 0.77 | GSK3A (0.34) | L3MBTL1 | |
| SCHEMBL1106715 | 0.77 | F2 (0.33) | F2ELANECTSGCTRCL3MBTL1 | |
| SCHEMBL6362036 | 0.77 | F2 (0.33) | F2ELANECTSGCTRCL3MBTL1 | |
| SCHEMBL6362000 | 0.77 | CHRM2 (0.33) | F2ELANECTSGCTRC | |
| SCHEMBL21389226 | 0.77 | PDE7A (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448414-B1 | STABILIZED AND ACTIVATED BROMINE SOLUTIONS AS A BIOCIDE AND AS AN ANTIFOULING AGENT | BROMINE COMPOUNDS LTD (IL) | 2019-04-24 | — | — | EP | claimed |
| EP-1556547-B1 | ADDITIVE AND METHOD FOR AVOIDING OR AT LEAST REDUCING DEPOSITS IN WATER BEARING AND/OR CONTACTING INDUSTRIAL SYSTEMS | POHLEN ALFRED (LU) | 2010-05-12 | — | — | EP | claimed |
| EP-2165981-A1 | Antimicrobial water treatment | LONZA, INC. (US) | 2010-03-24 | — | — | EP | claimed |
| US-RE39021-E1 | Hydantoin-enhanced halogen efficacy in pulp and paper applications | LONZA INC. (US) | 2006-03-21 | — | — | US | claimed |
| EP-1556547-A1 | ADDITIVE AND METHOD FOR AVOIDING OR AT LEAST REDUCING DEPOSITS IN WATER BEARING AND/OR CONTACTING INDUSTRIAL SYSTEMS | Pohlen, Alfred (LU) | 2005-07-27 | — | — | EP | claimed |
| WO-2004031481-A1 | ADDITIVE AND METHOD FOR AVOIDING OR AT LEAST REDUCING DEPOSITS IN WATER BEARING AND/OR CONTACTING INDUSTRIAL SYSTEMS | POHLEN ALFRED (LU) | 2004-04-15 | — | — | WO | claimed |
| EP-0785909-B1 | HYDANTOIN-ENHANCED HALOGEN EFFICACY IN PULP AND PAPER APPLICATIONS | LONZA AG (US) | 2003-04-16 | — | — | EP | claimed |
| US-20030039580-A1 | Stable preservative formulations comprising halopropynyl compounds and butoxydiglycol solvent | LONZA INC. (US) | 2003-02-27 | — | — | US | claimed |
| JP-2002544144-A | — | — | 2002-12-24 | — | — | JP | claimed |
| WO-2002067685-A1 | STABLE PRESERVATIVE FORMULATIONS COMPRISING HALOPROPYNYL COMPOUNDS AND BUTOXYDIGLYCOL SOLVENT | LONZA INC. (US) | 2002-09-06 | — | — | WO | claimed |
| EP-0859692-A4 | HALOHYDANTOIN FORMS AND METHOD BY MELT EXTRUSION | LONZA AG (US) | 1999-02-03 | — | — | EP | claimed |
| EP-0859692-A1 | HALOHYDANTOIN FORMS AND METHOD BY MELT EXTRUSION | LONZA INC. (US) | 1998-08-26 | — | — | EP | claimed |
| US-5750061-A | EXTRUDING WITH PARTIAL MELTING FOR DUSTLESS SOLID PRODUCT | LONZA INC. (US) | 1998-05-12 | — | — | US | claimed |
| EP-0785909-A4 | HYDANTOIN-ENHANCED HALOGEN EFFICACY IN PULP AND PAPER APPLICATIONS | LONZA AG (US) | 1998-02-25 | — | — | EP | claimed |
| EP-0785909-A1 | HYDANTOIN-ENHANCED HALOGEN EFFICACY IN PULP AND PAPER APPLICATIONS | LONZA, INC. (US) | 1997-07-30 | — | — | EP | claimed |
| WO-1997017180-A1 | HALOHYDANTOIN FORMS AND METHOD BY MELT EXTRUSION | LONZA INC. (US) | 1997-05-15 | — | — | WO | claimed |
| US-5565109-A | SLIMICIDES | LONZA INC. (US) | 1996-10-15 | — | — | US | claimed |
| WO-1996011882-A1 | HYDANTOIN-ENHANCED HALOGEN EFFICACY IN PULP AND PAPER APPLICATIONS | LONZA INC. (US) | 1996-04-25 | — | — | WO | claimed |
| US-4560766-A | Shaped halogenated hydantoins | GLYCO CHEMICALS, INC. (US) | 1985-12-24 | — | — | US | claimed |
| US-4537697-A | Method of enhancing solubility of halogenated hydantoins | GLYCO, INC. (US) | 1985-08-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030039580-A1 | Stable preservative formulations comprising halopropynyl compounds and butoxydiglycol solvent | DDC, HDHD5, GMDS | F2 1597/4885ELANE 2323/4885CTSG 3379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.